National Health (Highly Specialised Drugs Program) Special Arrangement 2021
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Highly Specialised Drugs Program) Special Arrangement 2021
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Highly Specialised Drugs Program) Special Arrangement 2021.
(1) This section applies if: (a) an approved pharmacist or approved medical practitioner has supplied an HSD pharmaceutical benefit; and (b) the supply is a special arrangement supply of the benefit.
Note: However, see Part 3A in relation to a special arrangement supply of an HSD pharmaceutical benefit to a CTG registered patient by a CTG supplier.
(2) The approved pharmacist or approved medical practitioner is, subject to section 99AAA of the Act and the conditions determined under section 98C of the Act that are applicable at the time of the supply, entitled to be paid by the Commonwealth the amount, if any, by which the dispensed price for the supply of the benefit exceeds the amount that the approved pharmacist or approved medical practitioner was entitled to charge under section 87 of the Act in respect of the supply.
Note: Section 87 of the Act limits the amounts that approved pharmacists and approved medical practitioners can charge patients for the supply of pharmaceutical benefits.
(3) This section applies despite subsections 99(2) and (2AA) of the Act.